Tuesday, November 15, 2016
- 9:00AM-11:00AM
-
Abstract Number: 2969
10 Year Retrospective Analysis of 276 Cases of Histopathologically Confirmed Leukocytoclastic Vasculitis
Vasculitis - Poster III: Rarer Vasculitides- 9:00AM-11:00AM
-
Abstract Number: 2285
12/15-Lipoxygenase Inhibition By ML351 Protects Against Uric Acid Crystal-Induced Acute Arthritis in Mice
Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease- 9:00AM-11:00AM
-
Abstract Number: 2973
A Comparison of Caregiving Burden and Impact in Systemic Vasculitis Versus Other Conditions
Vasculitis - Poster III: Rarer Vasculitides- 9:00AM-11:00AM
-
Abstract Number: 2911
A Comparison of Gastrointestinal Disease Severity in African American and Caucasian Scleroderma Patients
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2601
A Cytometric Assay for Monitoring Adalimumab Immunogenicity and Drug Concentrations Can Distinguish Anti-Adalimumab Antibodies from Interference
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2240
A Descriptive Analysis of Real-World Treatment Patterns in a Turkish Rheumatology Population That Continued Innovator Infliximab (Remicade) Therapy or Switched to Biosimilar Infliximab
Health Services Research - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2266
A Melanocortin Fusion Peptide (AQB-565) Optimized for Melanocortin Receptor Engagement Significantly Reduces Inflammation in an In Vivo model of Acute Gout
Innate Immunity and Rheumatic Disease - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2780
A Modification of the Psoriatic Arthritis Disease Activity Score (mPASDAS) Using SF-12 As a Measure of Quality of Life
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2295
A Non-Linear Relationship Between Physical Activity and Serum Uric Acid Concentrations: Nhanes 2003-2004
Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease- 9:00AM-11:00AM
-
Abstract Number: 2561
A Novel Pharmacological Action of MTX on RA Fibroblast-like Synoviocytes Via Circadian Clock Genes
Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2343
A Phase 2, Multi-Center, Randomized, Double-Blind, Active-Controlled, Parallel Group Study to Evaluate the Safety and Dose Effectiveness of Intradermal Injections of Purified Apis Mellifera Toxin to Improve Pain and Physical Function in Patients with Osteoarthritis of the Knee
Osteoarthritis – Clinical Aspects - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2724
A Prospective Study of Ankylosing Spondylitis in China with Smart Management System for Spondyloarthritis: Study Design and Baseline Characteristics of the 449 Recruited Patients
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2488
A Randomised Controlled Trial Evaluating the Effect of Adalimumab upon Biomarkers of Cardiovascular Risk in ACPA-Positive Rheumatoid Arthritis